Although the clinical significance of common genetic variants associated with PCa risk remains unclear, breast cancer susceptibility gene 1 (BRCA1) and BRCA2 are closely associated with PCa invasiveness and prognosis (3). This evidence concerns the gene BRCA1 and posterior cortical atrophy.